HomeSearchJCO Oncology Advances

JCO Oncology Advances

Wolters Kluwer Health - Lippincott Williams Wilkins · United States

eISSN2994-9750
DOAJOpen Access
52
/ 100
Established
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
DOAJ-listed52
Total52

Aims & Scope

Subject areas: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Topics: oncology, global health, cancer research, clinical medicine, cancer, public health

General Information

Country / RegionUnited States
Primary LanguageEnglish
1st Year Published
StatusActive
Total Publications
Publisher OrgWolters Kluwer Health
Visit Journal Website

Submission Info

APC Cost$3,800Above median
Peer ReviewAnonymous peer review
Review Time
Acceptance Rate
OA LicenseCC BY, CC BY-NC-ND
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

9/12 · 75%
Do you know the journal / publisher?
Wolters Kluwer Health - Lippincott Williams Wilkins
Does the journal have a website?
✓ Linked
Is the ISSN verified?
2994-9750
Indexed in a trusted database?
DOAJ
Peer review process documented?
Anonymous peer review
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
$3,800
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
DOAJ verified
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Subject Classification

Research Topics (OpenAlex)

Pancreatic and Hepatic Oncology ResearchCancer Immunotherapy and BiomarkersEconomic and Financial Impacts of CancerGastric Cancer Management and OutcomesEthics in Clinical ResearchColorectal Cancer Treatments and StudiesColorectal Cancer Surgical TreatmentsLung Cancer Treatments and MutationsCancer Genomics and DiagnosticsCancer Treatment and Pharmacology

Frequently asked questions about JCO Oncology Advances

Is JCO Oncology Advances a predatory journal?

PubScope has no integrity flags on record for JCO Oncology Advances: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 52/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of JCO Oncology Advances?

JCO Oncology Advances is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.

Is JCO Oncology Advances indexed in Scopus and Web of Science?

JCO Oncology Advances is indexed in DOAJ.

What is the aims and scope of JCO Oncology Advances?

Subject areas: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens. Topics: oncology, global health, cancer research, clinical medicine, cancer, public health

How much does it cost to publish in JCO Oncology Advances?

JCO Oncology Advances charges an article processing charge (APC) of about $3,800 for open-access publication.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref